intravitreal pegaptanib

DRUG2 trials

Sponsors

Kagawa University Faculty of Medicine, L.V. Prasad Eye Institute

Conditions

Myopic Choroidal Neovascular MembranePersistent Cases of Exudative Age-related Macular Degeneration

Unknown Phase

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

WithdrawnNCT01218230

L.V. Prasad Eye InstituteMyopic Choroidal Neovascular Membrane

Start: 2010-12-31End: 2012-07-31Updated: 2015-09-02

The Effect of Switching Therapy to Pegaptanib in Eyes with the Persistent Cases of Exudative Age-related Macular Degeneration

Active, not recruitingJPRN-UMIN000020334

Kagawa University Faculty of MedicinePersistent Cases of Exudative Age-related Macular Degeneration

Start: 2010-04-01Target: 50Updated: 2026-06-29